CHAPTERS
- 0:00 – 2:51
Painkiller’s impact: personal losses and why Berg took the project
Joe praises Netflix’s Painkiller for making the opioid crisis accessible and emotionally hard to watch. Peter Berg explains why he committed to the series, citing people he knows who died and the shock of realizing how many lives opioids touched—including cultural heroes.
- 2:51 – 5:53
Sales tactics and “heroin in an M&M”: titration, incentives, and deception
They discuss how Purdue framed OxyContin as safe while pushing doctors to escalate doses. Berg details rep bonuses tied to pill strength and the “titrating up” strategy that fueled dependence and profit.
- 5:53 – 7:55
Settlement, immunity, and a Supreme Court twist
Rogan and Berg react to how the Sacklers avoided criminal prosecution through bankruptcy settlement terms. Berg breaks down the $6B over decades structure and notes the Supreme Court pause that reopened the question of accountability.
- 7:55 – 12:07
Docudrama accuracy, ‘hammer the abusers,’ and Netflix legal fears
Joe asks what in the series is factual versus dramatized. Berg cites documented internal strategies like blaming victims (“hammer the abusers”) and describes how legal concerns drove disclaimers and shaped how the show presented facts without letting Purdue off the hook.
- 12:07 – 14:00
How opioids became ‘normal’: granny’s prescription and the pipeline to fentanyl
Rogan shares an example of a 90-year-old on opioid meds and the surreal normalization of dependence. They connect prescription opioids to today’s fentanyl contamination crisis where even non-opioid street drugs can be lethal.
- 14:00 – 16:23
From ‘Heroin for coughs’ to modern pharma marketing: the long history
They look at vintage pharmaceutical ads and discuss the early eras of drug marketing. Berg links this history to Arthur Sackler’s marketing legacy and Purdue’s slogans and tactics.
- 16:23 – 24:29
What Oxy feels like—and why it hooks: warmth, relief, and then the crash
Berg recounts trying OxyContin recreationally and instantly understanding its appeal and danger. They describe how opioids erase physical and emotional pain, creating a powerful reinforcement loop that quickly turns destructive.
- 24:29 – 35:33
Regulatory capture: FDA approval, Curtis Wright, and the hotel-room mystery
Berg details how OxyContin’s approval hinged on one FDA official and questionable language about addiction risk. The conversation centers on the revolving door, alleged influence, and the moral implications of bureaucratic decisions with mass-casualty outcomes.
- 35:33 – 39:29
Reputation laundering: museums, naming rights, and the Nobel legacy parallel
They discuss how wealth from harmful products gets converted into prestige through philanthropy and naming rights. Berg compares Sackler legacy management to Alfred Nobel’s pivot from ‘merchant of death’ to the Nobel Prize brand.
- 39:29 – 48:13
Morality, sociopathy, and why accountability never comes
They explore how powerful people rationalize harm and avoid sincere contrition. The talk broadens into sociopathy, the absence of empathy, and how legal strategy can erase human acknowledgment of suffering.
- 48:13 – 1:05:42
Russia, nuclear fear, and the weapons economy: touring a Trident sub
The conversation pivots to geopolitics and war incentives, with Berg recounting a tour of a nuclear submarine and the staggering cost of weapons systems. They connect military spending incentives to the same profit-driven logic seen in pharma.
- 1:05:42 – 1:25:54
UAPs, Area 51 mushrooms, and secrecy vs. next-gen human tech
Rogan raises UFO/UAP theories, including the idea that ‘alien’ narratives could obscure classified propulsion breakthroughs. Berg shares a comedic Area 51 encounter while high, and they discuss secrecy, compartmentalization, and how fast tech accelerates.
- 1:25:54 – 1:46:28
Stem cells vs opioids: pain management, back injuries, and FDA suspicion
They return to pain care, comparing opioid prescriptions with regenerative medicine options like stem cells. Rogan shares personal surgery experiences and argues that regulatory inertia and pharma incentives may hinder broader stem-cell adoption in the U.S.
- 1:46:28 – 2:13:41
Fighter health, brain trauma, and the business of combat sports
They discuss long-term brain damage risks in boxing and MMA, including sparring practices and cognitive decline. Berg shares his boxing gym history (including Canelo’s arrival) and they debate boxing’s fragmented structure and a UFC-style ‘roll-up’ solution.
- 2:13:41 – 2:22:43
Money, priorities, and closing reflections: from opioid capture to military capture
In the final stretch, they tie together themes of profit-driven systems—pharma and weapons—crowding out investments in communities. Rogan and Berg argue for prioritizing schools, parks, and opportunity to reduce downstream crises like addiction.
